Results 101 to 110 of about 35,392 (213)
Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease [PDF]
Aims A hallmark of Fabry disease is the concomitant development of left-ventricular hypertrophy and arterial intima-media thickening, the pathogenesis of which is thought to be related to the presence of a plasmatic circulating growth-promoting factor ...
Barbey, Frédéric +7 more
core
Fabry disease is a rare cause of end-stage renal disease. Renal pathology is notable for diffuse deposition of glycosphingolipid in the renal glomeruli, tubules, and vasculature.
Hernán Trimarchi MD, PhD
doaj +1 more source
Fabry disease is the most frequently occurring form of lysosomal disease in Japan, and is characterized by a wide variety of conditions. Primarily, the three major types of concerns associated with Fabry disease observed during adulthood that must be ...
Hiroshi Kobayashi +4 more
doaj +1 more source
Clinical and Pathological Findings in Women with Fabry Disease [PDF]
Introduction. Fabry disease is a rare metabolic disorder caused by the genetic deficiency of the lysosomal hydrolase alpha-galactosidase A, located on chromosome X.
Carvalho, F +3 more
core
Origin of slow stress relaxation in the cytoskeleton
Dynamically crosslinked semiflexible biopolymers such as the actin cytoskeleton govern the mechanical behavior of living cells. Semiflexible biopolymers nonlinearly stiffen in response to mechanical loads, whereas the crosslinker dynamics allow for ...
Koenderink, Gijsje H. +2 more
core +2 more sources
Bilateral avascular necrosis: A rare complication of Fabry disease
Fabry disease is a rare X-linked lysosomal storage disorder caused by pathogenic variants in the GLA gene, which encodes for the α–galactosidase A enzyme responsible for degrading globotriaosylceramide.
Candela Romano +3 more
doaj +1 more source
Aortic remodelling in Fabry disease [PDF]
Aims To evaluate thoracic aortic dilation in patients with Fabry disease (FD). Methods and results A cohort of 106 patients with FD (52 males; 54 females) from three European centres were studied.
Barbey, Frédéric +8 more
core
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation [PDF]
Background. The purpose of this study was to identify determinants of renal disease progression in adults with Fabry disease during treatment with agalsidase beta. Methods.
Beitner-Johnson, Dana +15 more
core
Champagne Seas—Foretelling the Ocean’s Future? [PDF]
Imagine you are an ocean researcher and you want to study the ecological impacts of ocean acidification. You know from studies carried out under controlled laboratory conditions that lowered pH can impact the physiology, growth, and development of ...
Hall-Spencer, J, Rauer, E
core +1 more source

